{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:58:25Z","timestamp":1782788305850,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ando.2025.101790","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:35:34Z","timestamp":1747236934000},"page":"101790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and\/or metastatic thyroid cancer"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-4816","authenticated-orcid":false,"given":"Arnaud","family":"Jannin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Escande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Louvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Breuskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lamartina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101790_bib0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ando.2025.101790_bib0365","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2025.101790_bib0370","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0b013e3181b7faf6","article-title":"Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors","volume":"251","author":"Lee","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2025.101790_bib0375","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1634\/theoncologist.2015-0107","article-title":"Outcomes and prognostic factors in radioiodine refractory differentiated thyroid carcinomas","volume":"21","author":"Wassermann","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ando.2025.101790_bib0385","unstructured":"Sagnella A, Lasolle H, Godbert Y, Do Cao C, Drui D, Segolene H, et al. PRONOSThyC: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from the French ENDOCAN-TUTHYREF network 2024. (abstract presented in ETA congress 2024): https:\/\/www.endocrine-abstracts.org\/ea\/0101\/ea0101op-12-04."},{"key":"10.1016\/j.ando.2025.101790_bib0390","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0395","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/ERC-21-0368","article-title":"Metastatic medullary thyroid carcinoma: a new way forward","volume":"29","author":"Angelousi","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101790_bib0400","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000502229","article-title":"2019 European Thyroid Association Guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer","volume":"8","author":"Fugazzola","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2025.101790_bib0405","doi-asserted-by":"crossref","first-page":"1S40","DOI":"10.1016\/S0003-4266(16)30013-0","article-title":"Local treatment of metastases from differentiated thyroid cancer","volume":"76","author":"Bonichon","year":"2015","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2025.101790_bib0410","first-page":"e247072","article-title":"Definitive radiotherapy for oligometastatic and oligoprogressive thyroid cancer: a potential strategy for systemic therapy deferral","volume":"23","author":"Dudzinski","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ando.2025.101790_bib0415","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1470-2045(21)00332-6","article-title":"Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Brose","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/1078-0432.CCR-15-1127","article-title":"A phase II trial of the multitargeted tyrosine kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer","volume":"22","author":"Schlumberger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2025.101790_bib0425","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101790_bib0430","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ando.2025.101790_bib0435","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0440","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0445","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12020-021-02634-z","article-title":"Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution","volume":"73","author":"Porcelli","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101790_bib0450","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0455","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hed.23619","article-title":"Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement","volume":"36","author":"Shindo","year":"2014","journal-title":"Head Neck"},{"issue":"Suppl. 3","key":"10.1016\/j.ando.2025.101790_bib0460","first-page":"S18","article-title":"International neuromonitoring study group guidelines 2018: Part II: optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data","volume":"128","author":"Wu","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ando.2025.101790_bib0465","first-page":"1020","article-title":"Surgery for neck recurrence of differentiated thyroid cancer: outcomes and risk factors","volume":"102","author":"Lamartina","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101790_bib0470","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/hed.27735","article-title":"Neoadjuvant therapy to improve resectability of advanced thyroid cancer: a real-world experience","volume":"46","author":"Russell","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.ando.2025.101790_bib0475","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1089\/thy.2019.0133","article-title":"Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma","volume":"29","author":"Wang","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0480","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/coa.12730","article-title":"A national analysis of trends, outcomes and volume-outcome relationships in thyroid surgery","volume":"42","author":"Nouraei","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.ando.2025.101790_bib0485","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00423-020-01907-x","article-title":"Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis \u2013 European Society of Endocrine Surgeons (ESES) positional statement","volume":"405","author":"Lorenz","year":"2020","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ando.2025.101790_bib0490","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2008.05.012","article-title":"Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience","volume":"73","author":"Terezakis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2025.101790_bib0495","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jso.23656","article-title":"External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer","volume":"110","author":"Romesser","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0500","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3857\/roj.2017.00192","article-title":"The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ando.2025.101790_bib0505","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/thy.2018.0214","article-title":"Intensity-modulated radiation therapy with or without concurrent chemotherapy in nonanaplastic thyroid cancer with unresectable or gross residual disease","volume":"28","author":"Beckham","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0510","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1089\/thy.2012.0598","article-title":"Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer","volume":"24","author":"Blevins","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0515","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2265.2005.02358.x","article-title":"Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years","volume":"63","author":"Brierley","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101790_bib0520","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9343(81)90573-8","article-title":"Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients","volume":"70","author":"Mazzaferri","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2025.101790_bib0525","first-page":"714","article-title":"The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients","volume":"75","author":"Samaan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101790_bib0530","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jjco\/27.4.244","article-title":"Results of external beam radiotherapy in patients with well-differentiated thyroid carcinoma","volume":"27","author":"Lin","year":"1997","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0535","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1089\/thy.2016.0650","article-title":"Comparison of survival outcomes following postsurgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma","volume":"27","author":"Yang","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0540","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamaoto.2017.2077","article-title":"Adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer","volume":"143","author":"Tam","year":"2017","journal-title":"JAMA Otolaryngol\u00a0\u2013\u00a0Head Neck Surg"},{"key":"10.1016\/j.ando.2025.101790_bib0545","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/thy.2012.0403","article-title":"Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986\u20132009 Memorial Sloan-Kettering Cancer Center experience","volume":"23","author":"Ibrahimpasic","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0550","doi-asserted-by":"crossref","first-page":"572958","DOI":"10.3389\/fonc.2020.572958","article-title":"Treatment of unresectable differentiated thyroid carcinoma with upfront external radiotherapy and salvage surgery: a STROBE-compliant retrospective cohort study","volume":"10","author":"Carrillo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0555","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers11060849","article-title":"10-year locoregional control with postoperative external beam radiotherapy in patients with locally advanced high-risk non-anaplastic thyroid carcinoma de novo or at relapse, a propensity score analysis","volume":"11","author":"Servagi Vernat","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2025.101790_bib0560","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/hed.24513","article-title":"Comprehensive management of recurrent thyroid cancer: an American Head and Neck Society consensus statement: AHNS consensus statement","volume":"38","author":"Scharpf","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ando.2025.101790_bib0565","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1677\/erc.1.01320","article-title":"Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition","volume":"13","author":"Chow","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101790_bib0570","doi-asserted-by":"crossref","first-page":"e210033","DOI":"10.1530\/ETJ-21-0033","article-title":"Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer","volume":"11","author":"Groen","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2025.101790_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101790_bib0580","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2147\/CMAR.S340967","article-title":"Management of progressive radioiodine-refractory thyroid carcinoma: current perspective","volume":"14","author":"Nervo","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ando.2025.101790_bib0585","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00268-018-4813-5","article-title":"Usefulness of stereotactic radiotherapy using the CyberKnife for patients with inoperable locoregional recurrences of differentiated thyroid cancer","volume":"43","author":"Ishigaki","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101790_bib0590","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2012.09.007","article-title":"Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques","volume":"86","author":"Sun","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ando.2025.101790_bib0595","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2008.09.023","article-title":"Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment","volume":"74","author":"Schwartz","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2025.101790_bib0600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3413\/nukmed-0221","article-title":"Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer\u00a0\u2013\u00a0results after 874 patient-years of follow-up in the MSDS-trial","volume":"48","author":"Biermann","year":"2009","journal-title":"Nukl Nucl Med"},{"key":"10.1016\/j.ando.2025.101790_bib0605","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/oncolo\/oyac065","article-title":"Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit","volume":"27","author":"Wirth","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.ando.2025.101790_bib0610","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2022.04.009","article-title":"ESMO clinical practice guideline update on the use of systemic therapy in advanced thyroid cancer","volume":"33","author":"Filetti","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0615","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/cancers14041061","article-title":"Anaplastic thyroid carcinoma: an update","volume":"14","author":"Jannin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2025.101790_bib0620","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/jc.2012-1169","article-title":"Skeletal-related events due to bone metastases from differentiated thyroid cancer","volume":"97","author":"Farooki","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101790_bib0625","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1148\/radiol.2018181105","article-title":"Fluoroscopy and cone-beam CT-guided fixation by internal cemented screw for pathologic pelvic fractures","volume":"290","author":"Roux","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2025.101790_bib0630","doi-asserted-by":"crossref","first-page":"108693","DOI":"10.1016\/j.ejrad.2019.108693","article-title":"Corrigendum to \u201cThermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma\u201d [Eur. J. Radiol. 119 (2019) 108650]","volume":"121","author":"Barat","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ando.2025.101790_bib0635","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jrr\/rrz056","article-title":"Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer","volume":"60","author":"Ishigaki","year":"2019","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.ando.2025.101790_bib0640","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine"},{"issue":"249","key":"10.1016\/j.ando.2025.101790_bib0645","first-page":"256","article-title":"Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures","author":"Mirels","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ando.2025.101790_bib0650","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2106\/00004623-198163040-00017","article-title":"The management of acetabular insufficiency secondary to metastatic malignant disease","volume":"63","author":"Harrington","year":"1981","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ando.2025.101790_bib0655","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00270-019-02314-6","article-title":"Preventive vertebroplasty for long-term consolidation of vertebral metastases","volume":"42","author":"Delpla","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ando.2025.101790_bib0660","doi-asserted-by":"crossref","first-page":"e200137","DOI":"10.1148\/rycan.2021200137","article-title":"Prophylactic percutaneous consolidation of large osteolytic tumors of the pelvic ring using fixation by internal cemented screws","volume":"3","author":"Assouline","year":"2021","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.ando.2025.101790_bib0665","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1148\/radiol.2020201341","article-title":"Image-guided percutaneous fixation with internal cemented screws of impending femoral neck pathologic fractures in patients with metastatic cancer: safety, efficacy, and durability","volume":"297","author":"Dassa","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2025.101790_bib0670","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.diii.2014.04.017","article-title":"Treatment of hepatic and pulmonary metastases with radiofrequency","volume":"95","author":"de Baere","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.ando.2025.101790_bib0675","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdv037","article-title":"Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases","volume":"26","author":"de Ba\u00e8re","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0680","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00066-012-0107-2","article-title":"Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies","volume":"188","author":"Nieder","year":"2012","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.ando.2025.101790_bib0685","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0690","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ando.2025.101790_bib0695","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0700","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.101790_bib0705","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijrobp.2014.10.024","article-title":"Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis","volume":"91","author":"Sahgal","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2025.101790_bib0710","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet Lond Engl"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662500109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662500109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T12:49:52Z","timestamp":1751028592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342662500109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S000342662500109X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101790","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and\/or metastatic thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101790"}}